BSE filing, NSE: INDCEMCAP. Summary written from the filing by ALFA Finder's alert engine.
India Cements Capital Ltd: key numbers
- Share price
- ₹28.04
- Market cap
- ₹60.86 Cr
- Revenue (annual)
- ₹5.01 Cr
- Net profit (annual)
- ₹-0.45 Cr
- P/E (TTM)
- -100.0×Sector 19.7×
- Promoter holding
- 50.02%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from India Cements Capital Ltd
All →India Cements Capital Open Offer: ₹6.77 Cr
Acquirers have made an open offer to purchase up to 56.44 lakh equity shares of India Cements Capital Ltd at a price of ₹12 per share.
- Value
- ₹6.77 Cr
India Cements Capital Regulatory Approval
India Cements Capital Limited received RBI approval for the change in management control or ownership of more than 50 percent, in relation to the ongoing open offer.
India Cements Capital Annual General Meeting
India Cements Capital filed the 40th AGM proceedings summary from 15 September 2026. The chairman recapped FY2026 results and the open offer to buy the company's shares.
India Cements Capital Annual General Meeting
India Cements Capital Limited will hold its 40th Annual General Meeting on September 15, 2026. The company also filed its Annual Report for the fiscal year 2026.
India Cements Capital Open Offer: ₹6.77 Cr
The acquirers filed a Draft Letter of Offer to purchase up to 56,43,612 shares of India Cements Capital Ltd. The open offer is valued at ₹6.77 Crore.
- Value
- ₹6.77 Cr
India Cements Capital Management Change
India Cements Capital Limited reappointed Mr. K. Suresh as Manager/CEO and Mr. V. Manickam as Non-Executive Director. The Board also convened the upcoming Annual General Meeting.
- Execution
- 01.10.2026 to 30.09.2027
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.